Wolverine Stack – BPC-157 + TB-500

Description

Wolverine Stack combines BPC-157 (gut-derived pentadecapeptide) with TB-500 (Thymosin Beta-4 active fragment) at a 1:1 ratio for paired pathway research.

Mechanism: BPC-157 drives angiogenesis via VEGFR-2 and cytoprotective nitric oxide effects; TB-500 enables cell migration through actin cytoskeleton modulation. The combination engages both vascularisation and cellular motility – the two rate-limiting components of soft-tissue repair.

Research findings: The pairing is a long-standing reference in connective tissue, tendon, ligament and post-traumatic recovery research, often invoked in models requiring both angiogenic and migratory contributions.

Handling: Lyophilized peptide. Store sealed at -20°C for long-term stability or 2-8°C short-term. Reconstitute with bacteriostatic water or 0.6% acetic acid as appropriate to the molecule.

For research purposes only. Not for human consumption. This material is intended exclusively for in-vitro laboratory and preclinical research applications conducted by qualified personnel.